A panel of leading reinsurance executives provide perspective on topics to include cell and gene therapy, structured reinsurance, reinsurance demand for value based care arrangements, and how reinsurers view a variety of risk transfer opportunities.
{{ day.Date }}
{{ time.Time }}
{{ session.Description }}
{{ session.Description }}